Bone formation and bioresorption after implantation of injectable β-tricalcium phosphate granules-hyaluronate complex in rabbit bone defects

Journal of Biomedical Materials Research - Part A

Volumn 70, Issue 4, 2004, Pages 542-549

  Chazono, Masaaki ^a   Tanaka, Takaaki ^b   Komaki, Hirokazu ^a   Fujii, Katsuyuki ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kawachi gun   (Japan)

Author keywords

Beta tricalcium phosphate ( TCP); Bioresorption; Bone formation; Hyaluronate; Injectable

Indexed keywords

BIODEGRADATION; CELLS; ENZYMES; EVALUATION; IMPLANTS (SURGICAL); SORPTION;

BIORESORPTION; TRICALCIUM PHOSPHATE;

BONE;

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BIOMATERIAL; CALCIUM PHOSPHATE; FILLER; HYALURONIC ACID; MINERAL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIODEGRADABILITY; BIODEGRADATION; BIORESORPTION; BONE DEFECT; CELL ACTIVITY; CELL SUBPOPULATION; CONDUCTANCE; ENZYME ACTIVITY; FEMUR CONDYLE; GIANT CELL; INJECTION; MINERALIZATION; NONHUMAN; OSSIFICATION; OSTEOCONDUCTIVITY; OSTEOLYSIS; RABBIT;

EID: 4344565873     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30094     Document Type: Article

References (29)

1. Aurori BF, Weierman RJ, Lowell HA, Nadel CI, Parsons JR. Pseudarthrosis after spinal fusion for scoliosis. A comparison of autogenic and allogenic bone grafts. Clin Orthop 1985;199:153-158.
2. Karcher HL. HTV transmitted by bone graft. BMJ 1997;14:1300.
3. Kitsugi T, Yamamoto T, Nakamura T, Kotani S, Kokubo T, Takeuchi H. Four calcium phosphate ceramics as bone substitutes for non-weight-bearing. Biomaterials 1993;14:216-224.
4. Hoogendoorn HA, Renooij W, Akkermans LMA, Visser DDS, Wittebol P. Long-term study of large ceramic implants in dog femora. Clin Orthop 1984;187:281-288.
5. Oyake Y, Beppu M, Ishi S, Takagi M, Takashi M. Intramedullary anchoring strength of titanium rod with mixed β-tricalcium phosphate and fibrin adhesive. J Orthop Sci 2002;7:123-130.
6. Ozawa M. Experimental study on bone conductivity and absorbability of the pure β-TCP. J Jpn Soc Biomater 1995;13:167-175.
7. Saito M, Shimizu H, Beppu M, Takagi M. The role of β-tricalcium phosphate in vascularized periosteum. J Orthop Sci 2000; 5:275-282.
8. Dong J, Uemura T, Shirasaki Y, Tateishi T. Promotion of bone formation using highly pure porous β-TCP combined with bone marrow-derived osteogenitor cells. Biomaterials 2002;23: 4493-4502.
9. Meyer K, Palmer JW. The polysaccharide of the vitreous humor. J Biol Chem 1934;107:629-634.
10. West DC, Hampson IN, Arnold F, Kumar S. Angiogenesis induced by degradation products of hyaluronic acid. Science 1985;228:1324-1326.
11. Rooney P, Wang M, Kumar P, Kumar S. Angiogenic oligosaccharides of hyaluronan enhance the production of collagens by endothelial cells. J Cell Sci 1993;105:213-218.
12. Lee VC, Fan TPD, West DC. Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest 1995;73:259-266.
13. Sasaki T, Watanabe C. Stimulation of osteoinduction in bone wound healing by high-molecular weight hyaluronic acid. Bone 1995;16:9-15.
14. Pilloni A, Bernard GW. The effect of hyaluronan on mouse intramembranous osteogenesis in vitro. Cell Tissue Res 1998; 294:323-333.
15. Oonishi H, Hench LL, Wison J, Sugihara F, Tsuji E, Kushitani S, Iwaki H. Comparative bone growth behavior in granules of bioceramic materials of various sizes. J Biomed Mater Res 1999;44:31-43.
16. Gauthier O, Bouler JM, Weiss P, Bosco J, Aguado E, Daculsi G. Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution. Bone 1999;25:71-74S.
17. Eggli PS, Muller W, Shenk RK. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in cancellous bone of rabbits. Clin Orthop 1988;232:127-138.
18. Shimazaki K, Mooney V. Comparative study of porous hydroxyapatite and tricalcium phosphate as bone substitute. 1985;3:301-310.
19. Jarcho M. Calcium phosphate ceramics as hard tissue prosthesis. Clin Orthop 1981;157:259-278.
20. De Groot K. Bioceramics consisting of calcium phosphate salts. Biomaterials 1980;1:47-50.
21. Kotani S, Fujita Y, Kitsugi T, Nakamura T, Yamamuro T. Bone bonding mechanism of β-tricalcium phosphate. J Biomed Mater Res 1991;25:1303-1315.
22. Bhaskar SN, Brady JM, Getter L, Growen MF, Driskell T. Biodegradable ceramic implants in bone. Oral Surg 1971;32: 336-346.
23. Renooij W, Hoogendoorn HA, Visser WJ, Lentferink RHF, Schmitz MGJ, Ieperen HV, Oldenburg SJ, Janssen WM, Akkermans LMA, Wittebol P. Bioresorption of ceramic strontium-SS-labeled calcium phosphate implants in dog femora: a pilot study to quantitate bioresorption of ceramic implants of hydroxyapatite and tricalcium orthophosphate in vivo. Clin Orthop 1985;197:272-285.
24. Athanasou NA. Cellular biology of bone-resorbing cells. J Bone Joint Surg Am 1996;78-A:1096-1112.
25. Radomsky ML, Aufdemorte TB, Swain LD. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in non-human primates. J Orthop Res 1999;17: 6604-6614.
26. Fouissac E, Milas M, Rinaudo M. Shear-rate, concentration, molecular weight, and temperature viscosity dependences of hyaluronate, a wormlike polyelectrolyte. Macromolecules 1993;26:6945-6951.
27. Miyamoto Y, Ishikawa K, Takeuchi M, Toh T, Yoshida Y, Nagayama M, Kon M, Asaoka K. Tissue response to fastsetting calcium phosphate cement in bone. J Biomed Mater Res 1997;37:457-464.
28. Munting E, Mirtchi AA, Lemaitre J. Bone repair of defects filled with a phosphocalcic hydraulic cement: in vivo study. J Mater Sci Mater Med 1993;4:337-344.
29. Daculsi G. Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute. Biomaterials 1998;19:1473-1478.